Skip to search formSkip to main contentSkip to account menu

artemether / lumefantrine

Known as: ARTEMETHER/LUMEFANTRINE, Artemether and Lumefantrine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
  • 2015
  • Corpus ID: 13183378
Methods—We searched PubMed for clinical trials that enrolled and treated patients with artemether–lumefantrine and were published… 
2013
2013
BackgroundMalaria remains a major public health problem in developing countries. Then in these countries prompt access to… 
2012
Highly Cited
2011
Highly Cited
2011
ABSTRACT Artemether-lumefantrine and nevirapine-based antiretroviral therapy (ART) are the most commonly recommended first-line… 
Highly Cited
2011
Highly Cited
2011
ABSTRACT There are sparse published data relating to the pharmacokinetic properties of artemether, lumefantrine, and their active… 
Highly Cited
2010
Highly Cited
2010
BackgroundSafety data regarding exposure to artemisinin-based combination therapy in pregnancy are limited. This prospective… 
2009
2009
Background Repeated antimalarial treatment for febrile episodes and self-treatment are common in malaria-endemic areas. The… 
2006
2006
This randomized, open-label study compared a three-day, six-dose regimen of artemether-lumefantrine with a five-day, 19-dose… 
2006
2006
ObjectiveTo determine the pharmacokinetic properties of artemether and lumefantrine (AL) in pregnant women with recrudescent… 
Review
2006
Review
2006
BACKGROUND The World Health Organization recommends artemether-lumefantrine, an expensive drug, as a treatment for uncomplicated…